A.C. PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
A.C. PHARMA
Largest movements
- Receivables within one year -€333,474
down €333,474 (-74.6%), from €447,016 to €113,542
of which Trade receivables: -€279,713
- Stocks and contracts +€70,255
up €70,255 (+340.4%), from €20,638 to €90,893
- Trade debts -€166,236
down €166,236 (-52.6%), from €316,021 to €149,785
- Profit (loss) carried forward -€74,212
down €74,212 (-80.4%), from €92,278 to €18,066
- Tax, wage and social debts +€50,296
up €50,296 (+262.9%), from €19,130 to €69,427
of which Taxes: +€39,895
- Current portion of long-term debt -€40,494
down €40,494 (-100.0%), from €40,494 to €0
- Other debts -€37,802
down €37,802 (-100.0%), from €37,802 to €0
- Gross operating margin -€148,433
down €148,433 (-39.4%), from €376,832 to €228,400
- Taxes -€73,620
down €73,620 (-100.0%), from €73,620 to €0
- Staff costs +€61,239
up €61,239 (+29.0%), from €211,095 to €272,335
- Other operating charges -€10,841
down €10,841 (-82.2%), from €13,183 to €2,342
- Write-downs +€10,000
up €10,000, from -€10,000 to €0
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €531,125 | €262,678 | -€268,447 | -50.5% |
| Fixed assets | 21/28 | €8,586 | €6,521 | -€2,065 | -24.0% |
| Tangible fixed assets | 22/27 | €8,223 | €6,158 | -€2,065 | -25.1% |
| Plant, machinery and equipment | 23 | €5,959 | €2,016 | -€3,943 | -66.2% |
| Furniture and vehicles | 24 | €2,265 | €4,142 | +€1,878 | +82.9% |
| Financial fixed assets | 28 | €363 | €363 | = | 0.0% |
| Current assets | 29/58 | €522,538 | €256,156 | -€266,382 | -51.0% |
| Stocks and contracts in progress | 3 | €20,638 | €90,893 | +€70,255 | +340.4% |
| Stocks | 30/36 | €20,638 | €90,893 | +€70,255 | +340.4% |
| Amounts receivable within one year | 40/41 | €447,016 | €113,542 | -€333,474 | -74.6% |
| Trade receivables | 40 | €367,357 | €87,644 | -€279,713 | -76.1% |
| Other amounts receivable | 41 | €79,659 | €25,898 | -€53,761 | -67.5% |
| Cash at bank and in hand | 54/58 | €54,839 | €51,721 | -€3,117 | -5.7% |
| Deferred charges and accrued income | 490/1 | €46 | €0 | -€46 | -100.0% |
| Total equity and liabilities | 10/49 | €531,125 | €262,678 | -€268,447 | -50.5% |
| Equity | 10/15 | €117,678 | €43,466 | -€74,212 | -63.1% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €13,000 | €13,000 | = | 0.0% |
| Tax-exempt reserves | 132 | €13,000 | €13,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €92,278 | €18,066 | -€74,212 | -80.4% |
| Amounts payable | 17/49 | €413,446 | €219,212 | -€194,235 | -47.0% |
| Amounts payable after more than one year | 17 | €0 | - | = | |
| Financial debts | 170/4 | €0 | - | = | |
| Amounts payable within one year | 42/48 | €413,446 | €219,212 | -€194,235 | -47.0% |
| Current portion of amounts payable after more than one year | 42 | €40,494 | €0 | -€40,494 | -100.0% |
| Trade debts | 44 | €316,021 | €149,785 | -€166,236 | -52.6% |
| Suppliers | 440/4 | €316,021 | €149,785 | -€166,236 | -52.6% |
| Taxes, remuneration and social security | 45 | €19,130 | €69,427 | +€50,296 | +262.9% |
| Taxes | 450/3 | - | €39,895 | +€39,895 | |
| Remuneration and social security | 454/9 | €19,130 | €29,532 | +€10,401 | +54.4% |
| Other amounts payable | 47/48 | €37,802 | €0 | -€37,802 | -100.0% |
| Remuneration, social security and pensions | 62 | €211,095 | €272,335 | +€61,239 | +29.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,857 | €3,605 | +€1,748 | +94.1% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€10,000 | €0 | +€10,000 | |
| Other operating charges | 640/8 | €13,183 | €2,342 | -€10,841 | -82.2% |
| Non-recurring operating charges | 66A | €47,405 | €20,087 | -€27,319 | -57.6% |
| Gross operating margin | 9900 | €376,832 | €228,400 | -€148,433 | -39.4% |
| Operating profit (loss) | 9901 | €113,291 | -€69,968 | -€183,260 | |
| Financial charges | 65/66B | €5,049 | €4,244 | -€805 | -15.9% |
| Recurring financial charges | 65 | €5,049 | €4,244 | -€805 | -15.9% |
| Profit (loss) for the period before taxes | 9903 | €108,242 | -€74,212 | -€182,455 | |
| Income taxes | 67/77 | €73,620 | €0 | -€73,620 | -100.0% |
| Profit (loss) for the period | 9904 | €34,622 | -€74,212 | -€108,834 | |
| Profit (loss) for the period to be appropriated | 9905 | €34,622 | -€74,212 | -€108,834 |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.